|
|
|
|
| LEADER |
03196nam a22004695i 4500 |
| 001 |
978-3-319-50174-1 |
| 003 |
DE-He213 |
| 005 |
20170317153804.0 |
| 007 |
cr nn 008mamaa |
| 008 |
170317s2017 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319501741
|9 978-3-319-50174-1
|
| 024 |
7 |
|
|a 10.1007/978-3-319-50174-1
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a R-RZ
|
| 072 |
|
7 |
|a MBGR
|2 bicssc
|
| 072 |
|
7 |
|a MED000000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 610
|2 23
|
| 245 |
1 |
0 |
|a Sigma Receptors: Their Role in Disease and as Therapeutic Targets
|h [electronic resource] /
|c edited by Sylvia B. Smith, Tsung-Ping Su.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2017.
|
| 300 |
|
|
|a XIII, 312 p. 59 illus., 45 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|x 0065-2598 ;
|v 964
|
| 505 |
0 |
|
|a Foreword -- Chap. 1 Anti-depressant functions of sigma receptor 1 -- Chap. 2 Parkinsonism -- Chap. 3 New ligands for sigma receptors and studies of ligand binding sites -- Chap. 4 σR1 and neurite elongation -- Chap. 5 Studies of σR1 in ALS, photaffinity probes and oxidative stress -- Chap. 6 σR1: Pharmacology and protective effects -- Chap. 7 Anti-stroke and anti-excitotoxicity -- Chap. 8 σR1 as a molecular chaperone -- Chap. 9 The potential role of σR1 as a neuroprotective -- Chap. 10 Studies of σR1 and effects on VGCC (calcium channels) -- Chap. 11 The role of σR1 in retinal neuroprotection -- Index.
|
| 520 |
|
|
|a Originally confused with opioid receptors and then orphan receptors with no biological function, Sigma Receptors are now recognized as relevant to many degenerative diseases with remarkable potential as therapeutic targets. In this text, new information about the structure of sigma 1 receptor, its binding sites are provided as well as its expression in many cell types. It’s putative role in degenerative neuronal diseases including amyotrophic lateral sclerosis, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, pain, drug addiction and locomotor activity. Their roles in possible treatments for blinding retinal diseases emphasize the tremendous far-reaching potential for ligands for these receptors. Exciting breakthroughs in this dynamic field in the last decade are reported herein, which will guide future investigators in determining the full potential of this unique, yet abundantly expressed protein.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Proteins.
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Biomedicine general.
|
| 650 |
2 |
4 |
|a Protein Science.
|
| 650 |
2 |
4 |
|a Receptors.
|
| 700 |
1 |
|
|a Smith, Sylvia B.
|e editor.
|
| 700 |
1 |
|
|a Su, Tsung-Ping.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319501727
|
| 830 |
|
0 |
|a Advances in Experimental Medicine and Biology,
|x 0065-2598 ;
|v 964
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-319-50174-1
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
